Current treatment practices for anemia in patients with chronic kidney disease and future opportunities with hypoxia-inducible factor prolyl hydroxylase inhibitors: a narrative review

被引：0
|
作者：
Mercedes Kile
Patcharaporn Sudchada
机构：
[1] University of Wisconsin-Madison,School of Pharmacy
[2] Naresuan University,Faculty of Pharmaceutical Sciences
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; Anemia; Iron; ESA; Hypoxia-inducible factor prolyl hydroxylase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 290
页数：7
相关论文
共 50 条
  • [1] Current treatment practices for anemia in patients with chronic kidney disease and future opportunities with hypoxia-inducible factor prolyl hydroxylase inhibitors: a narrative review
    Kile, Mercedes
    Sudchada, Patcharaporn
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 283 - 290
  • [2] Hypoxia-inducible factor?prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease
    Haase, Volker H.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2021, 11 (01) : 8 - 25
  • [3] Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
    Souza, Ernane
    Cho, Katherine H.
    Harris, Shelby T.
    Flindt, Naomi R.
    Watt, Richard K.
    Pai, Amy Barton
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 831 - 844
  • [4] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease
    Bartnicki, Piotr
    BIOMEDICINES, 2024, 12 (08)
  • [5] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia
    Abraham, Abi
    Almeida, Alan
    Bhalla, Anil Kumar
    Chaudury, Arpita Ray
    Dutta, Arup Ratan
    Gupta, Ashwani
    Shah, Bharat
    Roy, Biswajeet
    Subbarao, Budithi
    Herath, Chula
    Amrutha, Cynthia
    Shah, Dibya Singh
    Pahari, Dilip Kumar
    Khullar, Dinesh
    Bajpai, Divya
    Simaladinne, Guruvulu Venkata
    Kothari, Jatin
    Tyagi, Jyoti
    Sharma, Inika
    Shah, Kamal
    Malik, Manish
    Sahay, Manisha
    Sharma, Manjuri
    Gumber, Manoj
    Sreelatha, Melemadathil
    Tiwaskar, Mangesh
    Kaur, Manveen
    Alam, Muhammed Rafiqul
    Gopalakrishnan, Natarajan
    Prasad, Narayan
    Kamath, Nivedita
    Meena, Priti
    Varma, Prem Prakash
    Das, Pratik
    Ramachandran, Raja
    Sharma, Raj Kumar
    George, Reena
    Jain, Salil
    Ingale, Samiksha
    Moola, Sandeep
    Bhattacharya, Sandip Kumar
    D'Cruz, Sanjay
    Gulati, Sanjeev
    Saxena, Sanjiv
    Sundar, Sankaran
    Acharya, Shivnarayan
    Bansal, Shyam Bihari
    Vishwanath, Siddini
    Gang, Sishir
    Raju, Sree Bhushan
    INDIAN JOURNAL OF NEPHROLOGY, 2025, 35 (02) : 129 - 167
  • [6] Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors
    Sugahara, Mai
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    PHARMACOLOGY & THERAPEUTICS, 2022, 239
  • [7] Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease
    Kurata, Yu
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (04) : 414 - 422
  • [8] Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease Anemia
    Wang, Xue
    Wei, Cuiting
    Zhao, Delong
    Sun, Xuefeng
    Zhu, Fengge
    Mei, Yan
    Ma, Qian
    Cai, Guangyan
    Chen, Xiangmei
    Li, Ping
    KIDNEY DISEASES, 2023, 9 (06) : 485 - 497
  • [9] Daprodustat: A Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia of Chronic Kidney Disease
    Johnson, Haley N.
    Prasad-Reddy, Lalita
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 71 - 80
  • [10] Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis
    Ren, Song
    Zhao, Yurong
    Wu, Jingyu
    Ren, Shangqing
    Feng, Yunlin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345